Illuminare Biotechnologies IncIB
SEC Form D filing

Illuminare Biotechnologies Inc

Biotech · Series A · Regulation D 506(b) · NY · Filed June 4, 2026

Offering amount
$4.0M
Exemption
Reg D 506(b)
Issuer state
NY
Filing date
June 4, 2026
Signature date
June 4, 2026
CIK
0001701523

Summary

Auto-generated

Biotechnology company, $4M Series A in NY.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.